Research into medicinal cannabis continues to progress, and Tarkus Pharma Lab, in collaboration with the Complutense University of Madrid, has developed an innovative preclinical study on the effects of CBD on aging and cellular health.
This study, presented at the Spanish National Academy of Medicine, revealed that cannabidiol (CBD) could play a key role in reducing oxidative stress and inflammation—two of the main factors that accelerate aging and tissue degradation.
The Potential of CBD in Modern Medicine
Cannabis and its derivatives have been recognized by the World Health Organization (WHO) for their therapeutic potential in diseases such as cancer, Parkinson’s, and Alzheimer’s, thanks to their antioxidant and anti-inflammatory properties. With this new research, Tarkus Pharma Lab reinforces the evidence that CBD can neutralize the effects of cellular aging and improve immune function.
Aging is an inevitable process, but scientific studies have shown that additional antioxidants can slow its progression and reduce the incidence of chronic diseases. According to Dr. Jesús Tresguerres, leader of the research, the beneficial effects of CBD have been widely validated through key biomarkers, opening new opportunities for its clinical application.
Towards New Treatments Based on Pharmaceutical Cannabis
Pharmaceutical CBD therapy not only has the potential to slow aging but could also reduce the adverse effects of conventional treatments and improve the quality of life for patients.
Alejandro Venegas, CEO of Tarkus Pharma Lab, highlights that these findings represent a disruptive advance in cannabinoid-based medicine, supporting its application in areas such as cellular health, neuroprotection, and chronic inflammation reduction.
Next Steps in Research
Tarkus Pharma Lab will continue developing clinical studies to validate the use of CBD in advanced medical therapies, consolidating its position as a leader in pharmaceutical innovation based on cannabis.
📢 Follow our updates and discover how Tarkus is transforming the future of medicinal cannabis.